April 24th, 2014
This week’s topics include trials of aspirin and clonidine in patients undergoing noncardiac surgery, changes in diabetes-related complications in the U.S., and more.
March 31st, 2014
Myocardial infarction (MI) is among the most common and serious side effects of noncardiac surgery. An effective regimen to minimize this risk has been the subject of considerable debate in recent years. The controversy was recently exacerbated because the recommendation to use beta-blockers in this setting was based on research which has now been discredited. Substantial […]